These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15613867)
1. INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor. Blokx WA; Ruiter DJ; Verdijk MA; de Wilde PC; Willems RW; de Jong EM; Ligtenberg MJ Am J Surg Pathol; 2005 Jan; 29(1):125-30. PubMed ID: 15613867 [TBL] [Abstract][Full Text] [Related]
2. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
3. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
4. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779 [TBL] [Abstract][Full Text] [Related]
5. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation. Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918 [TBL] [Abstract][Full Text] [Related]
6. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient. Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439 [TBL] [Abstract][Full Text] [Related]
7. Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver. Weihrauch M; Markwarth A; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A Hum Pathol; 2002 Sep; 33(9):884-92. PubMed ID: 12378512 [TBL] [Abstract][Full Text] [Related]
8. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients. Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234 [TBL] [Abstract][Full Text] [Related]
9. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265 [TBL] [Abstract][Full Text] [Related]
10. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status. Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544 [TBL] [Abstract][Full Text] [Related]
12. CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin. Küsters-Vandevelde HV; Van Leeuwen A; Verdijk MA; de Koning MN; Quint WG; Melchers WJ; Ligtenberg MJ; Blokx WA Int J Cancer; 2010 May; 126(9):2123-32. PubMed ID: 19739123 [TBL] [Abstract][Full Text] [Related]
13. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. Soufir N; Daya-Grosjean L; de La Salmonière P ; Moles JP; Dubertret L; Sarasin A; Basset-Seguin N J Natl Cancer Inst; 2000 Nov; 92(22):1841-7. PubMed ID: 11078762 [TBL] [Abstract][Full Text] [Related]
14. The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations. Olcha P; Cybulski M; Skomra D; Obrzut B; Ignatov A; Jóźwik M; Schneider-Stock R; Semczuk A Int J Gynecol Cancer; 2010 Aug; 20(6):993-9. PubMed ID: 20683407 [TBL] [Abstract][Full Text] [Related]
16. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. Brown VL; Harwood CA; Crook T; Cronin JG; Kelsell DP; Proby CM J Invest Dermatol; 2004 May; 122(5):1284-92. PubMed ID: 15140233 [TBL] [Abstract][Full Text] [Related]
17. Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas. Campos MA; Macedo S; Fernandes MS; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640663 [No Abstract] [Full Text] [Related]
19. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
20. Selective deletion of p14(ARF) exon 1beta of the INK4a locus in oral squamous cell carcinomas of Indians. Viswanathan M; Tsuchida N; Shanmugam G Oral Oncol; 2001 Jun; 37(4):341-4. PubMed ID: 11337265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]